Skip to main content

Security report for amplexa.com

Amplexa Genetics A/S · Healthcare · Denmark

Medium risk. 5 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

72/100

Risk levelMedium

0–100, higher is better. How it is calculated

Amplexa Genetics A/S is a Denmark-based healthcare company specializing in advanced genetic testing services, including fertility solutions, clinical diagnostics, neurology-related genetic tests, and research & development support. The company targets healthcare professionals, fertility clinics, patients, and research institutions, positioning itself as a specialized provider with innovative offerings such as non-invasive preimplantation genetic testing (niPGT-A) and comprehensive carrier screening programs. The website reflects a mature business with a domain age of over 17 years, consistent with its market presence. Technically, the website is built on modern frameworks including Next.js and React, with content managed via Sanity CMS. It is hosted on One.com and employs best practices such as HTTPS, cookie consent mechanisms, and responsive design, ensuring a fast and accessible user experience. The site integrates Stripe for payment processing and uses Cookiebot for privacy compliance. From a security perspective, the site demonstrates good posture with HTTPS enforcement, security headers, and encrypted communication for sensitive data. However, DNSSEC is not enabled, and no dedicated security policy or incident response page is present, which are areas for improvement. No vulnerabilities or suspicious patterns were detected. Overall, Amplexa Genetics presents a professional, trustworthy, and compliant online presence suitable for its healthcare sector audience. Strategic recommendations include enabling DNSSEC, publishing a security policy, and establishing a vulnerability disclosure program to enhance trust and security maturity.

Scanned

NIS2 and GDPR posture

GDPR outside view
65/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      Third-party services without privacy policy

      Detected services: Facebook, LinkedIn, YouTube, Google APIs

      What to do: Document all third-party data sharing in your privacy policy

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching amplexa.com

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
30
Email security
85
DNS health
80
Network security
100
GDPR outside view
65
Average
72

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention amplexa.com, from OffSeq Breach.

No leaked records found

Breach holds no records for amplexa.com right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Amplexa Genetics operates in the healthcare sector with a focus on genetic testing services. Its business model combines B2B and B2C approaches, serving fertility clinics, healthcare professionals, and individual clients. The company leverages advanced genetic technologies to provide diagnostic and screening solutions, positioning itself competitively with innovative products like niPGT-A. Revenue streams likely include testing services, training programs, and research collaborations. The company maintains a professional digital presence with clear branding, comprehensive service descriptions, and active social media engagement. Growth indicators include recent content updates and a broad service portfolio. The partnership ecosystem includes formstack for order forms and Stripe for payments, indicating integration with reliable service providers.

Security posture

The website exhibits a mature security posture with mandatory HTTPS, multiple security headers, and encrypted email communication. Cookie consent is implemented, supporting GDPR compliance. The domain is protected against unauthorized transfers with clientTransferProhibited status. However, DNSSEC is not enabled, which could improve DNS security. No explicit security policy or incident response information is published, limiting transparency for security incidents. No vulnerability disclosure or security.txt file is present. No exposed sensitive data or vulnerable libraries were detected. Overall, the security posture is strong but could be enhanced by publishing security policies and enabling DNSSEC.

Recommendations

  1. Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
  2. Publish a dedicated security policy page outlining security practices and controls.
  3. Establish and publicize an incident response process and contact channels for security issues.
  4. Implement a vulnerability disclosure program or security.txt file to encourage responsible reporting.
  5. Regularly review and update third-party libraries and dependencies to mitigate vulnerabilities.

Contact details published on the site

Addresses
Legal name
Amplexa Genetics A/S
Registration number
29428441
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Amplexa Genetics A/S
Description
Amplexa Genetics offers cutting-edge genetic testing to help professionals diagnose and select appropriate treatment for their patients, with a focus on fertility, clinical genetics, neurology, and research & development.
Key services
Genetic testing for fertility, Clinical genetic diagnostics, Neurology genetic testing, Technical sequencing services, Research and development support, Carrier and donor screening programs
Content quality
excellent
Branding
consistent

Technology

Stack
Next.js, React, Stripe.js, Headless UI, Sanity CMS
Frameworks
Next.js, React
Platforms
Web
Performance
fast
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Client transfer prohibited domain status
  • Cookie consent implemented
  • Encrypted email communication mentioned

Analytics and tracking

Tracking level
minimal
Privacy practices
good

Advertising

Tracking pixels
Cookiebot
Marketing tools
Cookiebot
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is professionally designed with clear navigation and rich content.
  2. Strong focus on genetic testing services for fertility, clinical, neurology, and research sectors.
  3. Comprehensive legal and privacy documentation available.
  4. Contact information is clearly presented with multiple channels.
  5. No signs of blocking or WAF interference.
  6. Use of modern web technologies and CMS.
  7. Social media presence on Facebook and LinkedIn.
  8. No explicit security policy or incident response page found.
  9. No vulnerability disclosure or security.txt detected.
Technical notes

Notes

The website is built using Next.js and React frameworks, leveraging Sanity CMS for content management. It uses Stripe.js for payment processing and Cookiebot for cookie consent management. Hosting is provided by One.com, as indicated by the nameservers. The site is optimized for performance with preloading of critical assets and responsive design for mobile devices. Accessibility features are present, and SEO is supported by proper meta tags and Open Graph data. The technical infrastructure is modern and well-maintained, supporting a fast and user-friendly experience. Opportunities exist to further improve security by enabling DNSSEC and enhancing transparency around security policies.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with amplexa.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review amplexa.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.